{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:23:32Z","timestamp":1793024612473,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s40120-022-00417-w","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T16:30:37Z","timestamp":1668529837000},"page":"177-195","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database"],"prefix":"10.1007","volume":"12","author":[{"given":"Julie","family":"Chandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Georgieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-7201","authenticated-orcid":false,"given":"Urvi","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Kirson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Ching","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Westermeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Biglan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"417_CR1","unstructured":"Alzheimer's Association: about Lewy body dementia. https:\/\/www.alz.org\/alzheimers-dementia\/what-is-dementia\/types-of-dementia\/lewy-body-dementia Accessed July 15, 2021."},{"issue":"2","key":"417_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40120-019-00154-7","volume":"8","author":"AA Tahami Monfared","year":"2019","unstructured":"Tahami Monfared AA, Meier G, Perry R, Joe D. Burden of disease and current management of dementia with Lewy bodies: a literature review. Neurol Ther. 2019;8(2):289\u2013305. https:\/\/doi.org\/10.1007\/s40120-019-00154-7.","journal-title":"Neurol Ther"},{"issue":"1","key":"417_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.clinph.2015.06.020","volume":"127","author":"RA Cromarty","year":"2016","unstructured":"Cromarty RA, Elder GJ, Graziadio S, et al. Neurophysiological biomarkers for Lewy body dementias. Clin Neurophysiol. 2016;127(1):349\u201359. https:\/\/doi.org\/10.1016\/j.clinph.2015.06.020.","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"417_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/0004867419835029","volume":"53","author":"KS Chin","year":"2019","unstructured":"Chin KS, Teodorczuk A, Watson R. Dementia with Lewy bodies: challenges in the diagnosis and management. Aust N Z J Psychiatry. 2019;53(4):291\u2013303. https:\/\/doi.org\/10.1177\/0004867419835029.","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"417_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1212\/CON.0000000000000309","volume":"22","author":"SN Gomperts","year":"2016","unstructured":"Gomperts SN. Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia. Continuum (Minneap Minn). 2016;22(2):435\u201363. https:\/\/doi.org\/10.1212\/CON.0000000000000309.","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"417_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/WAD.0b013e318065c4a9","volume":"21","author":"F Bostr\u00f6m","year":"2007","unstructured":"Bostr\u00f6m F, J\u00f6nsson L, Minthon L, Londos E. Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2007;21(2):150\u20134. https:\/\/doi.org\/10.1097\/WAD.0b013e318065c4a9.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"417_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2019.01.005","volume":"50","author":"C Mueller","year":"2019","unstructured":"Mueller C, Soysal P, Rongve A, et al. Survival time and differences between dementia with Lewy bodies and Alzheimer\u2019s disease following diagnosis: a meta-analysis of longitudinal studies. Ageing Res Rev. 2019;50:72\u201380. https:\/\/doi.org\/10.1016\/j.arr.2019.01.005.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"417_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017504","volume":"7","author":"A Price","year":"2017","unstructured":"Price A, Farooq R, Yuan JM, Menon VB, Cardinal RN, O\u2019Brien JT. Mortality in dementia with Lewy bodies compared with Alzheimer\u2019s dementia: a retrospective naturalistic cohort study. BMJ Open. 2017;7(11):e017504. https:\/\/doi.org\/10.1136\/bmjopen-2017-017504.","journal-title":"BMJ Open"},{"key":"417_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.dadm.2017.12.001","volume":"10","author":"C Mueller","year":"2018","unstructured":"Mueller C, Perera G, Rajkumar AP, et al. Hospitalization in people with dementia with Lewy bodies: frequency, duration, and cost implications. Alzheimers Dement (Amst). 2018;10:143\u201352. https:\/\/doi.org\/10.1016\/j.dadm.2017.12.001.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"417_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3233\/JAD-190731","volume":"73","author":"LM Giil","year":"2020","unstructured":"Giil LM, Aarsland D. Greater variability in cognitive decline in Lewy body dementia compared to Alzheimer\u2019s disease. J Alzheimers Dis. 2020;73(4):1321\u201330. https:\/\/doi.org\/10.3233\/JAD-190731.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"417_CR11","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jamda.2020.06.006","volume":"21","author":"R Espinosa","year":"2020","unstructured":"Espinosa R, Davis M, Johnson S, Cline S, Weintraub D. Direct medical costs of dementia with Lewy bodies by disease complexity. J Am Med Dir Assoc. 2020;21(11):1696\u2013704. https:\/\/doi.org\/10.1016\/j.jamda.2020.06.006.","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"417_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cger.2018.06.007","volume":"34","author":"AM Sanford","year":"2018","unstructured":"Sanford AM. Lewy body dementia. Clin Geriatr Med. 2018;34(4):603\u201315. https:\/\/doi.org\/10.1016\/j.cger.2018.06.007.","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"417_CR13","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40120-020-00198-0","volume":"9","author":"AA Tahami Monfared","year":"2020","unstructured":"Tahami Monfared AA, Desai M, Hughes R, Lucherini S, Yi Y, Perry R. Treatment options for dementia with Lewy bodies: a network meta-analysis of randomised control trials. Neurol Ther. 2020;9(2):521\u201334. https:\/\/doi.org\/10.1007\/s40120-020-00198-0.","journal-title":"Neurol Ther"},{"key":"417_CR14","unstructured":"U.S. Food and Drug Administration: Exelon\u00ae: Highlights of prescribing information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2007\/022083lbl.pdf Accessed July 15, 2021."},{"key":"417_CR15","unstructured":"European Medicines Agency: Rivastigmine Actavis. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rivastigmine-actavis Accessed July 15, 2021."},{"issue":"15","key":"417_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1080\/14656566.2018.1519548","volume":"19","author":"G Palermo","year":"2018","unstructured":"Palermo G, Ceravolo R, Bonuccelli U. Advances in the pharmacotherapeutic management of dementia with Lewy bodies. Expert Opin Pharmacother. 2018;19(15):1643\u201353. https:\/\/doi.org\/10.1080\/14656566.2018.1519548.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"417_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010357","volume":"6","author":"A Rongve","year":"2016","unstructured":"Rongve A, Soennesyn H, Skogseth R, et al. Cognitive decline in dementia with Lewy bodies: a 5-year prospective cohort study. BMJ Open. 2016;6(2):e010357. https:\/\/doi.org\/10.1136\/bmjopen-2015-010357.","journal-title":"BMJ Open"},{"issue":"1","key":"417_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/brain\/awz311","volume":"143","author":"E Matar","year":"2020","unstructured":"Matar E, Shine JM, Halliday GM, Lewis SJG. Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework. Brain. 2020;143(1):31\u201346. https:\/\/doi.org\/10.1093\/brain\/awz311.","journal-title":"Brain"},{"issue":"3","key":"417_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00702-019-02129-2","volume":"127","author":"A Martini","year":"2020","unstructured":"Martini A, Weis L, Schifano R, et al. Differences in cognitive profiles between Lewy body and Parkinson\u2019s disease dementia. J Neural Transm (Vienna). 2020;127(3):323\u201330. https:\/\/doi.org\/10.1007\/s00702-019-02129-2.","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"417_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3233\/JAD-161109","volume":"57","author":"MG Kramberger","year":"2017","unstructured":"Kramberger MG, Auestad B, Garcia-Ptacek S, et al. Long-term cognitive decline in dementia with Lewy bodies in a large multicenter international cohort. J Alzheimers Dis. 2017;57(3):787\u201395. https:\/\/doi.org\/10.3233\/JAD-161109.","journal-title":"J Alzheimers Dis"},{"issue":"5 Suppl","key":"417_CR21","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.jalz.2012.10.010","volume":"9","author":"DP Gill","year":"2013","unstructured":"Gill DP, Hubbard RA, Koepsell TD, et al. Differences in rate of functional decline across three dementia types. Alzheimers Dement. 2013;9(5 Suppl):S63-71. https:\/\/doi.org\/10.1016\/j.jalz.2012.10.010.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"417_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/WAD.0b013e3182037edf","volume":"25","author":"DP Gill","year":"2011","unstructured":"Gill DP, Koepsell TD, Hubbard RA, Kukull WA. Risk of decline in functional activities in dementia with Lewy bodies and Alzheimer disease. Alzheimer Dis Assoc Disord. 2011;25(1):17\u201323. https:\/\/doi.org\/10.1097\/WAD.0b013e3182037edf.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"417_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1192\/bjp.2019.195","volume":"216","author":"AO Vik-Mo","year":"2020","unstructured":"Vik-Mo AO, Giil LM, Borda MG, Ballard C, Aarsland D. The individual course of neuropsychiatric symptoms in people with Alzheimer\u2019s and Lewy body dementia: 12-year longitudinal cohort study. Br J Psychiatry. 2020;216(1):43\u20138. https:\/\/doi.org\/10.1192\/bjp.2019.195.","journal-title":"Br J Psychiatry"},{"issue":"10","key":"417_CR24","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/gps.4933","volume":"33","author":"AO Vik-Mo","year":"2018","unstructured":"Vik-Mo AO, Giil LM, Ballard C, Aarsland D. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study. Int J Geriatr Psychiatry. 2018;33(10):1361\u20139. https:\/\/doi.org\/10.1002\/gps.4933.","journal-title":"Int J Geriatr Psychiatry"},{"key":"417_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.trci.2019.06.005","volume":"5","author":"JS Andrews","year":"2019","unstructured":"Andrews JS, Desai U, Kirson NY, Zichlin ML, Ball DE, Matthews BR. Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer\u2019s disease clinical trials. Alzheimers Dement (N Y). 2019;5:354\u201363. https:\/\/doi.org\/10.1016\/j.trci.2019.06.005.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"417_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12874-021-01228-7","volume":"21","author":"JA Watt","year":"2021","unstructured":"Watt JA, Veroniki AA, Tricco AC, Straus SE. Using a distribution-based approach and systematic review methods to derive minimum clinically important differences. BMC Med Res Methodol. 2021;21(1):41. https:\/\/doi.org\/10.1186\/s12874-021-01228-7.","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"417_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","volume":"125","author":"KA Jellinger","year":"2018","unstructured":"Jellinger KA. Dementia with Lewy bodies and Parkinson\u2019s disease-dementia: current concepts and controversies. J Neural Transm (Vienna). 2018;125(4):615\u201350. https:\/\/doi.org\/10.1007\/s00702-017-1821-9.","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"417_CR28","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3233\/JAD-170274","volume":"59","author":"R Skogseth","year":"2017","unstructured":"Skogseth R, Hortobagyi T, Soennesyn H, et al. Accuracy of clinical diagnosis of dementia with Lewy bodies versus neuropathology. J Alzheimers Dis. 2017;59(4):1139\u201352. https:\/\/doi.org\/10.3233\/JAD-170274.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"417_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/wad.0000000000000279","volume":"32","author":"L Besser","year":"2018","unstructured":"Besser L, Kukull W, Knopman DS, et al. Version 3 of the National Alzheimer\u2019s Coordinating Center\u2019s uniform data set. Alzheimer Dis Assoc Disord. 2018;32(4):351\u20138. https:\/\/doi.org\/10.1097\/wad.0000000000000279.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"8","key":"417_CR30","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nly049","volume":"77","author":"LM Besser","year":"2018","unstructured":"Besser LM, Kukull WA, Teylan MA, et al. The revised National Alzheimer\u2019s Coordinating Center\u2019s neuropathology form-available data and new analyses. J Neuropathol Exp Neurol. 2018;77(8):717\u201326. https:\/\/doi.org\/10.1093\/jnen\/nly049.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"417_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/mdc3.12163","volume":"2","author":"KA Wyman-Chick","year":"2015","unstructured":"Wyman-Chick KA, Scott BJ. Development of clinical dementia rating scale cutoff scores for patients with Parkinson\u2019s disease. Mov Disord Clin Pract. 2015;2(3):243\u20138. https:\/\/doi.org\/10.1002\/mdc3.12163.","journal-title":"Mov Disord Clin Pract"},{"issue":"11","key":"417_CR32","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412\u20134. https:\/\/doi.org\/10.1212\/wnl.43.11.2412-a.","journal-title":"Neurology"},{"issue":"4","key":"417_CR33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"417_CR34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/WAD.0000000000000111","volume":"30","author":"SE Monsell","year":"2016","unstructured":"Monsell SE, Dodge HH, Zhou XH, et al. Results from the NACC uniform data set neuropsychological battery crosswalk study. Alzheimer Dis Assoc Disord. 2016;30(2):134\u20139. https:\/\/doi.org\/10.1097\/WAD.0000000000000111.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"4","key":"417_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/mds.26498","volume":"31","author":"M Lawton","year":"2016","unstructured":"Lawton M, Kasten M, May MT, et al. Validation of conversion between mini-mental state examination and Montreal cognitive assessment. Mov Disord. 2016;31(4):593\u20136. https:\/\/doi.org\/10.1002\/mds.26498.","journal-title":"Mov Disord"},{"issue":"3","key":"417_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323\u20139. https:\/\/doi.org\/10.1093\/geronj\/37.3.323.","journal-title":"J Gerontol"},{"issue":"4","key":"417_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/01.wad.0000213865.09806.92","volume":"20","author":"JC Morris","year":"2006","unstructured":"Morris JC, Weintraub S, Chui HC, et al. The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer disease centers. Alzheimer Dis Assoc Disord. 2006;20(4):210\u20136. https:\/\/doi.org\/10.1097\/01.wad.0000213865.09806.92.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"417_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/wad.0000000000000223","volume":"32","author":"S Weintraub","year":"2018","unstructured":"Weintraub S, Besser L, Dodge HH, et al. Version 3 of the Alzheimer Disease Centers\u2019 neuropsychological test battery in the uniform data set (UDS). Alzheimer Dis Assoc Disord. 2018;32(1):10\u20137. https:\/\/doi.org\/10.1097\/wad.0000000000000223.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"417_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WAD.0b013e318191c7dd","volume":"23","author":"S Weintraub","year":"2009","unstructured":"Weintraub S, Salmon D, Mercaldo N, et al. The Alzheimer\u2019s Disease Centers\u2019 uniform data set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009;23(2):91\u2013101. https:\/\/doi.org\/10.1097\/WAD.0b013e318191c7dd.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"417_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233\u20139. https:\/\/doi.org\/10.1176\/jnp.12.2.233.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"417_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ncl.2017.01.004","volume":"35","author":"D Galasko","year":"2017","unstructured":"Galasko D. Lewy body disorders. Neurol Clin. 2017;35(2):325\u201338. https:\/\/doi.org\/10.1016\/j.ncl.2017.01.004.","journal-title":"Neurol Clin"},{"issue":"15","key":"417_CR42","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1002\/mds.22322","volume":"23","author":"JG Goldman","year":"2008","unstructured":"Goldman JG, Goetz CG, Brandabur M, Sanfilippo M, Stebbins GT. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Mov Disord. 2008;23(15):2248\u201350. https:\/\/doi.org\/10.1002\/mds.22322.","journal-title":"Mov Disord"},{"issue":"2","key":"417_CR43","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"JP Taylor","year":"2020","unstructured":"Taylor JP, McKeith IG, Burn DJ, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19(2):157\u201369. https:\/\/doi.org\/10.1016\/S1474-4422(19)30153-X.","journal-title":"Lancet Neurol"},{"issue":"10004","key":"417_CR44","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D. Lewy body dementias. Lancet. 2015;386(10004):1683\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(15)00462-6.","journal-title":"Lancet"},{"issue":"1","key":"417_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/wad.0000000000000412","volume":"35","author":"R Espinosa","year":"2021","unstructured":"Espinosa R, Davis M, Johnson S, Cline S, Weintraub D. A model to assess the outcomes associated with dementia with Lewy bodies. Alzheimer Dis Assoc Disord. 2021;35(1):68\u201374. https:\/\/doi.org\/10.1097\/wad.0000000000000412.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"417_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13195-020-00703-5","volume":"12","author":"JG Goldman","year":"2020","unstructured":"Goldman JG, Forsberg LK, Boeve BF, et al. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials. Alzheimers Res Ther. 2020;12(1):137. https:\/\/doi.org\/10.1186\/s13195-020-00703-5.","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"417_CR47","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s40520-018-1087-6","volume":"31","author":"SL Burke","year":"2019","unstructured":"Burke SL, Hu T, Naseh M, et al. Factors influencing attrition in 35 Alzheimer\u2019s disease centers across the USA: a longitudinal examination of the National Alzheimer\u2019s Coordinating Center\u2019s uniform data set. Aging Clin Exp Res. 2019;31(9):1283\u201397. https:\/\/doi.org\/10.1007\/s40520-018-1087-6.","journal-title":"Aging Clin Exp Res"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-022-00417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-022-00417-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-022-00417-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T15:25:30Z","timestamp":1673537130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-022-00417-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["417"],"URL":"https:\/\/doi.org\/10.1007\/s40120-022-00417-w","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"22 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}